In millions, except per share items | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Interest income: |
Interest income on loans | 81.5 | 67.6 | 64.2 | 66.2 | 84.6 | 113.2 | 133.9 | 141.2 |
Interest income on investments | | | | 3.5 | 4.7 | 5.0 | | 6.3 |
| 89.1 | 74.5 | 71.8 | 73.9 | 93.2 | 120.7 | 142.8 | 150.4 |
Total interest expense | 9.7 | 7.1 | 6.8 | 11.3 | 16.6 | 24.4 | 35.5 | 51.7 |
Net interest income | 79.4 | 67.4 | 65.0 | 62.7 | 76.6 | 96.3 | 107.3 | 98.7 |
Provision for loan losses | 4.8 | -3.6 | -6.6 | -7.2 | 3.1 | 132.1 | 35.6 | 39.2 |
Net interest income after provision for loan losses | 74.7 | 71.0 | 71.6 | 69.9 | 73.5 | -35.8 | 71.8 | 59.5 |
Deposit and loan fees | | | | 10.5 | 11.6 | 12.1 | | 11.7 |
Gain on sale of investments, net | 0.3 | 0.2 | 1.9 | | 0.8 | | 2.7 | 2.9 |
Other non-interest income | 15.8 | 14.3 | 17.0 | 3.2 | 3.5 | | 15.9 | 7.3 |
Total non-interest income | 16.1 | 14.5 | 18.9 | 13.6 | 15.9 | 14.0 | 18.6 | 21.9 |
Non-interest expenses | 63.2 | 58.2 | 56.9 | 55.3 | 63.3 | 90.2 | 69.2 | 60.9 |
Pre-tax income before non-recurring items | 27.9 | 27.2 | 38.0 | 28.2 | 26.1 | -112.0 | 26.7 | 20.6 |
Non-recurring items | 0.4 | | 4.4 | | | | 5.6 | |
Pre-tax income | 27.5 | 27.2 | 33.6 | 28.2 | 26.1 | -112.0 | 21.1 | 20.6 |
Income taxes | 9.8 | 9.8 | 12.6 | 10.8 | 9.9 | -43.7 | 9.7 | 7.6 |
Tax rate | 35.7% | 36.0% | 37.5% | 38.2% | 37.9% | 39.0% | 46.1% | 37.0% |
Net income | 17.7 | 17.4 | 21.0 | 17.4 | 12.4 | -72.5 | 7.2 | 8.8 |
Net margin | 19.5% | 20.4% | 23.2% | 20.9% | 13.9% | -81.9% | 7.9% | 7.3% |
|
Basic EPS | $0.95 | $0.92 | $1.08 | $0.89 | $0.64 | ($3.74) | $0.40 | $0.60 |
Diluted EPS | $0.94 | $0.91 | $1.08 | $0.89 | $0.64 | ($3.74) | $0.40 | $0.60 |
|
Shares outstanding (basic) | 18.7 | 19.0 | 19.4 | 19.5 | 19.4 | 19.4 | 17.8 | 14.7 |
Shares outstanding (diluted) | 18.9 | 19.1 | 19.6 | 19.6 | 19.4 | 19.4 | 17.9 | 14.7 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |